Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases April 12, 2021 OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD March 29, 2021 Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use March 23, 2021 Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics at Benzinga Global Biotech Small Cap Conference Mar 24, 2021 at 11:50 AM EDT Lineage Cell Therapeutics Fourth Quarter and Full Year 2020 Financial Results Earnings Call Mar 11, 2021 at 4:30 PM EST Lineage Cell Therapeutics at H.C. Wainwright & Co. Inc. Global Life Sciences Conference Mar 9, 2021 at 7:00 AM EST VIEW EVENTS & PRESENTATIONS
April 12, 2021 OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD
March 29, 2021 Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use
March 23, 2021 Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy
Lineage Cell Therapeutics at Benzinga Global Biotech Small Cap Conference Mar 24, 2021 at 11:50 AM EDT
Lineage Cell Therapeutics Fourth Quarter and Full Year 2020 Financial Results Earnings Call Mar 11, 2021 at 4:30 PM EST
Lineage Cell Therapeutics at H.C. Wainwright & Co. Inc. Global Life Sciences Conference Mar 9, 2021 at 7:00 AM EST
